Skip to main content
. 2019 Dec 31;1(2):101–109. doi: 10.35772/ghm.2019.01012

Figure 2.

Figure 2.

(A) Overall survival in patients with intestinal-type adenocarcinoma and with diffuse-type adenocarcinoma/other type in GELM. (B) Recurrence-free survival in patients with intestinal-type adenocarcinoma and with diffuse-type adenocarcinoma/other type in GELM. GELM, gastric/esophagogastric-junction liver metastasis.